Theratechnologies Inc. (TH.TO) Suspends Most Long-Term R&D Activities, Cuts Jobs
10/30/2012 6:45:19 AM
More...
|
Theratechnologies Inc. (TH.TO) CEO Exits Role as Company Tightens Third-Quarter Loss
10/12/2012 7:14:51 AM
More...
|
Theratechnologies Inc. (TH.TO) Cuts 60% of Workforce, Refocus for 2013
12/7/2011 8:08:26 AM
More...
|
Theratechnologies Inc. (TH.TO) President and CEO to Ring The NASDAQ Stock Market Opening Bell
6/15/2011 10:10:29 AM
More...
|
Theratechnologies Inc. (TH.TO) Adopts New R&D Business Model to Strengthen Its Growth Potential; Cuts 24 Jobs
6/2/2011 12:48:42 PM
More...
|
Theratechnologies Inc. (TH.TO) Announces a Distribution and Licensing Agreement for EGRIFTA(TM) in Latin America, Africa and the Middle East With Sanofi-Aventis (France) (SASY.PA)
12/6/2010 10:19:40 AM
More...
|
Notice of Conference Call & Media Advisory: Theratechnologies Inc. (TH.TO) Announces a Partnership Agreement
12/6/2010 9:05:10 AM
More...
|
Theratechnologies Inc. (TH.TO) Plans Early Adoption of International Financial Reporting Standards
12/2/2010 11:42:42 AM
More...
|
Theratechnologies Inc. (TH.TO) Welcomes the Arrival of Its New President and CEO
12/1/2010 6:25:27 AM
More...
|
FDA Approves Theratechnologies Inc. (TH.TO)'s EGRIFTA(TM) (Tesamorelin for Injection): First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-infected Patients with Lipodystrophy
11/11/2010 6:39:14 AM
More...
|
|